...
首页> 外文期刊>Vaccine >Study of integrated protective immunity induced in rhesus macaques by the intradermal administration of a bivalent EV71-CA16 inactivated vaccine
【24h】

Study of integrated protective immunity induced in rhesus macaques by the intradermal administration of a bivalent EV71-CA16 inactivated vaccine

机译:二价EV71-CA16灭活疫苗皮内施用岩体猕猴诱导综合保护免疫研究

获取原文
获取原文并翻译 | 示例

摘要

Enterovirus type 71 (EV71) and coxsackievirus A 16 (CA16) are recognized as the major pathogens responsible for human hand-foot-mouth disease. To develop a bivalent EV71-CA16 vaccine, rhesus macaques immunized with two doses of this vaccine via the intradermal route were challenged with EV71 or CA16, and their clinical symptoms, viral shedding, neutralizing antibodies, IFN-gamma-specific ELISpots, and tissue viral load were examined longitudinally. Specific immunity against EV71 and CA16 was observed in the macaques, which exhibited controlled proliferation of the EV71 and CA16 viruses and upregulated expression of immune-related genes compared with the controls. Furthermore, broad protection against EV71 and CA16 challenge without immunopathological effects was observed in all the immunized macaques. These studies suggest that the bivalent EV71-CA16 inactivated vaccine was effective against wildtype EV71 or CA16 viral challenge in rhesus macaques. (C) 2019 Elsevier Ltd. All rights reserved.
机译:肠道病毒类型71(EV71)和Coxsackievirus A 16(CA16)被认为是负责人脚口病的主要病原体。开发二价EV71-CA16疫苗,通过皮内途径用两剂这种疫苗免疫的恒河猴致攻击,攻击EV71或CA16,以及它们的临床症状,病毒脱落,中和抗体,IFN-γ特异性的ELISPOT和组织病毒纵向检查负荷。在猕猴中观察到针对EV71和Ca16的特异性免疫,与对照相比,在猕猴中观察到EV71和Ca16病毒的可控制增殖,并上调了免疫相关基因的表达。此外,在所有免疫猕猴中都观察到对EV71和CA16挑战的广泛保护,所有免疫猕猴都观察到没有免疫病理学作用。这些研究表明,二价EV71-CA16灭活的疫苗对恒河猴中的野生型EV71或Ca16病毒攻击有效。 (c)2019 Elsevier Ltd.保留所有权利。

著录项

  • 来源
    《Vaccine 》 |2020年第8期| 共11页
  • 作者单位

    Chinese Acad Med Sci &

    Peking Union Med Coll Inst Med Biol Yunnan Key Lab Vaccine Res &

    Dev Severe Infect Di Kunming 650118 Yunnan Peoples R China;

    Chinese Acad Med Sci &

    Peking Union Med Coll Inst Med Biol Yunnan Key Lab Vaccine Res &

    Dev Severe Infect Di Kunming 650118 Yunnan Peoples R China;

    Chinese Acad Med Sci &

    Peking Union Med Coll Inst Med Biol Yunnan Key Lab Vaccine Res &

    Dev Severe Infect Di Kunming 650118 Yunnan Peoples R China;

    Aimei Convac BioPharm Jiangsu Co Ltd Taizhou 225300 Jiangsu Peoples R China;

    Chinese Acad Med Sci &

    Peking Union Med Coll Inst Med Biol Yunnan Key Lab Vaccine Res &

    Dev Severe Infect Di Kunming 650118 Yunnan Peoples R China;

    Chinese Acad Med Sci &

    Peking Union Med Coll Inst Med Biol Yunnan Key Lab Vaccine Res &

    Dev Severe Infect Di Kunming 650118 Yunnan Peoples R China;

    Chinese Acad Med Sci &

    Peking Union Med Coll Inst Med Biol Yunnan Key Lab Vaccine Res &

    Dev Severe Infect Di Kunming 650118 Yunnan Peoples R China;

    Aimei Convac BioPharm Jiangsu Co Ltd Taizhou 225300 Jiangsu Peoples R China;

    Chinese Acad Med Sci &

    Peking Union Med Coll Inst Med Biol Yunnan Key Lab Vaccine Res &

    Dev Severe Infect Di Kunming 650118 Yunnan Peoples R China;

    Aimei Convac BioPharm Jiangsu Co Ltd Taizhou 225300 Jiangsu Peoples R China;

    Chinese Acad Med Sci &

    Peking Union Med Coll Inst Med Biol Yunnan Key Lab Vaccine Res &

    Dev Severe Infect Di Kunming 650118 Yunnan Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医学免疫学 ;
  • 关键词

    Enterovirus type 71 (EV71); Coxsackievirus A 16 (CA16); Bivalent vaccine; Rhesus macaques;

    机译:肠道病毒类型71(EV71);CoxSackeivirus A 16(CA16);二价疫苗;恒河猴猕猴;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号